Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
10

Summary

Conditions
  • Brain Cancer
  • Brain Metastases
  • Brain Metastases, Adult
Type
Interventional
Phase
Phase 1
Design
Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: This is a prospective, single-site, single-arm, phase 1 proof-of-concept study to assess the potential clinical utility of 18F-fluciclovine PET/CT as a functional integral biomarker for patients with large brain metastases (>2 cm) treated with Staged Stereotactic Radiosurgery (SSRS).Masking: None (Open Label)Primary Purpose: Prevention

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04689048
Collaborators
Blue Earth Diagnostics
Investigators
Principal Investigator: Rupesh R Kotecha, MD Miami Cancer Institute (MCI) at Baptist Health, Inc.